NYSEAMERICAN:RVP

Retractable Technologies Stock Forecast, Price & News

$12.27

+0.33 (+2.76 %)

(As of 07/29/2021 12:00 AM ET)

Add

Compare

Today's Range

$11.81

▼

$12.57

50-Day Range

$7.27

▼

$15.02

52-Week Range

$5.26

▼

$21.50

Volume292,475 shs

Average Volume797,075 shs

Market Capitalization$417.23 million

P/E Ratio9.37

Dividend YieldN/A

Beta1.79

30 days | 90 days | 365 days | Advanced Chart

Receive RVP News and Ratings via Email

Sign-up to receive the latest news and ratings for Retractable Technologies and its competitors with MarketBeat's FREE daily newsletter.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holder; allergy tray; IV safety catheter; Patient Safe syringes and Luer Caps; VanishPoint blood collection set; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

RVP Aug 2021 17.500 call
July 23, 2021 | ca.finance.yahoo.com

3 Value Stocks That Won't Stop Growing
July 23, 2021 | finance.yahoo.com

RVP Jul 2021 15.000 call
July 6, 2021 | sg.finance.yahoo.com

RVP Jul 2021 20.000 call
June 28, 2021 | ca.finance.yahoo.com

Retractable Technologies, Inc. Announces Buyback Plan and Payment of All Dividends
June 7, 2021 | finance.yahoo.com

Retractable Technologies, Inc. Amends HHS Delivery Order
June 3, 2021 | finance.yahoo.com

Retractable Technologies, Inc. to Receive Additional Funding From U.S. Government Under Technology Investment Agreement
May 25, 2021 | finance.yahoo.com

Retractable Technologies, Inc. Reports $23.4 Million in Operating Income for First Quarter Of 2021
May 17, 2021 | finance.yahoo.com

RVP May 2021 22.500 call
May 6, 2021 | ca.finance.yahoo.com

RVP May 2021 10.000 call
May 6, 2021 | ca.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:RVP
Previous SymbolNYSEMKT:RVP
CUSIPN/A
CIK946563
Webwww.vanishpoint.com
Phone(972) 294-1010
Employees210
Year FoundedN/A

Sales & Book Value

Annual Sales$81.86 million
Price / Sales5.10
Cash Flow$0.82 per share
Price / Cash Flow14.98
Book Value$1.50 per share
Price / Book8.18

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares34,004,000
Market Cap$417.23 million
Next Earnings Date8/13/2021 (Estimated)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.41 out of 5 stars

Medical Sector

1030th out of 2,214 stocks

Surgical & Medical Instruments Industry

103rd out of 185 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Retractable Technologies.

3.3 Community Rank

Outperform Votes
Retractable Technologies has received 86 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Retractable Technologies has received 43 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Retractable Technologies has received 66.67% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Retractable Technologies and other stocks. Vote “Outperform” if you believe RVP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RVP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Retractable Technologies does not currently pay a dividend.
Dividend Growth
Retractable Technologies does not have a long track record of dividend growth.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Retractable Technologies insiders have not sold or bought any company stock.
Percentage Held by Insiders
49.50% of the stock of Retractable Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
15.20% of the stock of Retractable Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Retractable Technologies is 9.37, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of Retractable Technologies is 9.37, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 40.15.
Price to Book Value per Share Ratio
Retractable Technologies has a P/B Ratio of 8.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Retractable Technologies (NYSEAMERICAN:RVP) Frequently Asked Questions

What stocks does MarketBeat like better than Retractable Technologies?

Wall Street analysts have given Retractable Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Retractable Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Retractable Technologies' next earnings date?

Retractable Technologies is scheduled to release its next quarterly earnings announcement on Friday, August 13th 2021.
View our earnings forecast for Retractable Technologies.

How were Retractable Technologies' earnings last quarter?

Retractable Technologies, Inc. (NYSEAMERICAN:RVP) issued its quarterly earnings data on Monday, May, 17th. The company reported $0.52 earnings per share for the quarter. The business had revenue of $50.07 million for the quarter. Retractable Technologies had a trailing twelve-month return on equity of 88.98% and a net margin of 34.67%.
View Retractable Technologies' earnings history.

Who are Retractable Technologies' key executives?

Retractable Technologies' management team includes the following people:

Mr. Thomas J. Shaw, Founder, Chairman, Pres & CEO (Age 70, Pay $516.72k)
Mr. John W. Fort III, Director, VP, CFO, Principal Accounting Officer & Treasurer (Age 52, Pay $204k)
Ms. Michele M. Larios, VP, Gen. Counsel & Sec. (Age 55, Pay $351.01k)
Mr. Russell B. Kuhlman, VP of Sales Devel. (Age 67, Pay $156.71k)
Ms. Kathryn M. Duesman, Exec. Director of Global Health (Age 58, Pay $284.52k)
Mr. Lawrence G. Salerno, Director of Operations (Age 61)
Ms. Patti S. King, Director of National Accounts (Age 63)

Who are some of Retractable Technologies' key competitors?

Some companies that are related to Retractable Technologies include Cardiovascular Systems (CSII), Sight Sciences (SGHT), Silk Road Medical (SILK), iRhythm Technologies (IRTC), Pulmonx (LUNG), Alphatec (ATEC), MiMedx Group (MDXG), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Atrion (ATRI), LeMaitre Vascular (LMAT), CryoLife (CRY), AngioDynamics (ANGO), SI-BONE (SIBN) and Bioventus (BVS).
View all of RVP's competitors.

What other stocks do shareholders of Retractable Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Retractable Technologies investors own include OPKO Health (OPK), Co-Diagnostics (CODX), iBio (IBIO), NVIDIA (NVDA), T2 Biosystems (TTOO), Advanced Micro Devices (AMD), Overstock.com (OSTK), Pfizer (PFE), CarParts.com (PRTS) and Dynavax Technologies (DVAX).

What is Retractable Technologies' stock symbol?

Retractable Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "RVP."

How do I buy shares of Retractable Technologies?

Shares of RVP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Retractable Technologies' stock price today?

One share of RVP stock can currently be purchased for approximately $12.27.

How much money does Retractable Technologies make?

Retractable Technologies has a market capitalization of $417.23 million and generates $81.86 million in revenue each year.

How many employees does Retractable Technologies have?

Retractable Technologies employs 210 workers across the globe.

What is Retractable Technologies' official website?

The official website for Retractable Technologies is www.vanishpoint.com.

Where are Retractable Technologies' headquarters?

Retractable Technologies is headquartered at 511 Lobo Ln, LITTLE ELM, TX 75068-5295, United States.

How can I contact Retractable Technologies?

Retractable Technologies' mailing address is 511 Lobo Ln, LITTLE ELM, TX 75068-5295, United States. The company can be reached via phone at (972) 294-1010 or via email at [email protected]

This page was last updated on 7/30/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here